Dr. Harris Lichtenstein CEO Omnimmune Corporation
Exhibit
10.23
▇▇.
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇
CEO
Omnimmune
Corporation
▇▇▇▇ ▇▇▇▇
▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇,
▇▇ ▇▇▇▇▇
Re:
That certain document entitled “Gift Agreement,” entered into by and among The
Ohio State University Medical Center (the “University”), The Ohio State
University Foundation (the “Foundation”) and Omnimmune Corp. (“Omnimmune”) as of
the 18th day of
April 2008 (the “Pledge”) – Payment Schedule Modification
As of
July 11, 2008, the status of the commitments Omnimmune Corporation made to the
Foundation in accordance with the Agreement to support research as conducted by
▇▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ at the University is as follows (the “Pledge”):
| Pledge | ||||
|
Amount
Pledged
|
$ | 1,000,000 | ||
|
Amount
Paid
|
$ | 0 | ||
|
Amount
Due
|
$ | 1,000,000 | ||
Per the
telephone conference call held prior to June 30th, 2008,
the agreed upon payment schedule for the Pledge is outlined below. Please
note the first payment is due July 31, 2008 not June 30, 2008 as stated in the
Pledge. This letter serves as an amendment to the Pledge as follows (the
“Amendment”):
|
·
|
$100,000
by 7/31/08
|
|
·
|
$100,000
by 12/31/08
|
|
·
|
$100,000
by 6/30/09
|
|
·
|
$100,000
by 12/31/09
|
|
·
|
$100,000
by 6/30/10
|
|
·
|
$100,000
by 12/31/10
|
|
·
|
$100,000
by 6/30/11
|
|
·
|
$100,000
by 12/31/11
|
|
·
|
$100,000
by 6/30/12
|
|
·
|
$100,000
by 12/31/12
|
Except as
modified hereby, all of the terms and provisions of the Pledge shall remain in
full force and effect. This Amendment and Pledge shall constitute the
entire agreement between the parties with respect to the subject matter hereof
and supersede all prior or contemporaneous agreements and understandings among
the parties with respect thereto.
If you
have any questions or concerns about these agreements, please contact
me.
Sincerely,
/s/ ▇▇▇▇▇ ▇.
▇▇▇▇▇▇
▇▇▇▇▇ ▇.
▇▇▇▇▇▇
▇▇. Vice
President for Development
President,
The Ohio State University Foundation